BridgeBio Pharma, Inc. Common Stock (NASDAQ: BBIO) last traded at $65.75, up 0.61% on the session. The quote above updates while this page is open; the figures below are drawn from BridgeBio Pharma, Inc. Common Stock’s own filings and are restated only when a new one is published.
BridgeBio Pharma, Inc. Common Stock trades on NASDAQ under the ticker BBIO. Its market capitalisation is $12.85 billion.
Valuation measures for BridgeBio Pharma, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $12.85B |
|---|---|
| Enterprise value | $15.90B |
| Price / sales | 18.03 |
| Beta | 1.16 |
Trailing-twelve-month figures tagged in BridgeBio Pharma, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $713.07M |
| Net income (TTM) | -$702.02M |
|---|
| EPS (TTM) | -$3.57 |
|---|
| Gross margin | 94.44% |
|---|
| Operating margin | -69.81% |
|---|
| Cash | $677.91M |
|---|
Range and volume for BBIO over the past 52 weeks.
| 52-week high | $93.42 |
|---|---|
| 52-week low | $52.75 |
| Volume | 1.78M |
| Average volume | 2.40M |
| Previous close | $65.35 |
Invest a chosen dollar amount in BridgeBio Pharma, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell BBIO.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.